These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34163366)

  • 1. Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK.
    Yang Y; Wu Y; Zou J; Wang YH; Xu MX; Huang W; Yu DJ; Zhang L; Zhang YY; Sun XD
    Front Pharmacol; 2021; 12():687095. PubMed ID: 34163366
    [No Abstract]   [Full Text] [Related]  

  • 2. Icaritin Attenuates Lipid Accumulation by Increasing Energy Expenditure and Autophagy Regulated by Phosphorylating AMPK.
    Wu Y; Yang Y; Li F; Zou J; Wang YH; Xu MX; Wang YL; Li RX; Sun YT; Lu S; Zhang YY; Sun XD
    J Clin Transl Hepatol; 2021 Jun; 9(3):373-383. PubMed ID: 34221923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
    Zhang J; Du H; Shen M; Zhao Z; Ye X
    J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect and mechanism of Qiwei Tiexie capsule on 3T3-L1 adipocytes cells and rats with nonalcoholic fatty liver disease by regulating LXRα, PPARγ, and NF-κB-iNOS-NO signaling pathways.
    Suolang PC; Liu BQ; Chen J; De J; Nima ZB; Dunzhu CR
    J Ethnopharmacol; 2019 May; 236():316-325. PubMed ID: 30851372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway.
    Shi C; Xue W; Han B; Yang F; Yin Y; Hu C
    Eur J Pharmacol; 2019 May; 850():15-22. PubMed ID: 30753863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Huazhi Rougan Granules attenuates steatosis in cell model of nonalcoholic fatty liver disease by inducing autophagy].
    Shi YM; Fu ZH; Zhu CS; Li XP
    Zhongguo Zhong Yao Za Zhi; 2023 Apr; 48(7):1770-1778. PubMed ID: 37282951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psoralen Suppresses Lipid Deposition by Alleviating Insulin Resistance and Promoting Autophagy in Oleate-Induced L02 Cells.
    Wang Y; Wang Y; Li F; Zou J; Li X; Xu M; Yu D; Ma Y; Huang W; Sun X; Zhang Y
    Cells; 2022 Mar; 11(7):. PubMed ID: 35406631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK; Dai W; Zheng YW; Zhao SP
    Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrogen sulfide reduces serum triglyceride by activating liver autophagy via the AMPK-mTOR pathway.
    Sun L; Zhang S; Yu C; Pan Z; Liu Y; Zhao J; Wang X; Yun F; Zhao H; Yan S; Yuan Y; Wang D; Ding X; Liu G; Li W; Zhao X; Liu Z; Li Y
    Am J Physiol Endocrinol Metab; 2015 Dec; 309(11):E925-35. PubMed ID: 26442880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OM2, a Novel Oligomannuronate-Chromium(III) Complex, Promotes Mitochondrial Biogenesis and Lipid Metabolism in 3T3-L1 Adipocytes via the AMPK-PGC1α Pathway.
    Hao J; Hao C; Zhang L; Liu X; Zhou X; Dun Y; Li H; Li G; Zhao X; An Y; Liu J; Yu G
    PLoS One; 2015; 10(7):e0131930. PubMed ID: 26176781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance.
    Zheng H; Li S; Ma L; Cheng L; Deng C; Chen Z; Xie C; Xiang M; Jiang W; Chen L
    Eur J Pharmacol; 2011 Jun; 659(2-3):244-51. PubMed ID: 21463618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuciferine Inhibited the Differentiation and Lipid Accumulation of 3T3-L1 Preadipocytes by Regulating the Expression of Lipogenic Genes and Adipokines.
    Xu H; Wang L; Yan K; Zhu H; Pan H; Yang H; Liu M; Gong F
    Front Pharmacol; 2021; 12():632236. PubMed ID: 33841152
    [No Abstract]   [Full Text] [Related]  

  • 13. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
    Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
    World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine Ameliorates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Rats via Activation of SIRT3/AMPK/ACC Pathway.
    Zhang YP; Deng YJ; Tang KR; Chen RS; Liang S; Liang YJ; Han L; Jin L; Liang ZE; Chen YN; Yang QH
    Curr Med Sci; 2019 Feb; 39(1):37-43. PubMed ID: 30868489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway.
    Fang Y; Ji L; Zhu C; Xiao Y; Zhang J; Lu J; Yin J; Wei L
    Front Cell Dev Biol; 2020; 8():602574. PubMed ID: 33330497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
    Fu D; Cui H; Zhang Y
    Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crocetin ameliorates non-alcoholic fatty liver disease by modulating mitochondrial dysfunction in L02 cells and zebrafish model.
    Xu Z; Lin S; Tong Z; Chen S; Cao Y; Li Q; Jiang Y; Cai W; Tong Y; Zahra BS; Wang P
    J Ethnopharmacol; 2022 Mar; 285():114873. PubMed ID: 34848360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats.
    Tan Y; Kim J; Cheng J; Ong M; Lao WG; Jin XL; Lin YG; Xiao L; Zhu XQ; Qu XQ
    World J Gastroenterol; 2017 Jun; 23(21):3805-3814. PubMed ID: 28638220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway.
    Xue W; Wang J; Jiang W; Shi C; Wang X; Huang Y; Hu C
    Eur J Pharmacol; 2020 Mar; 871():172910. PubMed ID: 31926991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.